STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLX
  4. [Form 4] CLOROX CO /DE/ Insider Trading Activity

[Form 4] CLOROX CO /DE/ Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clorox director Christopher J. Williams reported two compensation-related awards of deferred stock units. On May 8, 2026, he received 297.0104 deferred stock units, and on June 30, 2026, he received 288.1391 deferred stock units.

The filing explains these units were acquired through dividend reinvestment during the fiscal year and by electing to receive quarterly director fees in deferred stock units under the Independent Directors' Deferred Compensation Plan. Each unit represents a 1-for-1 right to receive Clorox common stock, to be settled in shares after his retirement or other termination of board service. Following the latest award, Williams holds a total of 22,659.7313 deferred stock units directly.

Positive

  • None.

Negative

  • None.
Insider WILLIAMS CHRISTOPHER J
Role null
Type Security Shares Price Value
Grant/Award Deferred Stock Units 288.139 $0.00 --
Grant/Award Deferred Stock Units 297.01 $0.00 --
Holdings After Transaction: Deferred Stock Units — 22,659.731 shares (Direct, null)
Footnotes (1)
  1. 1-for-1 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WILLIAMS CHRISTOPHER J
(Last)(First)(Middle)
1221 BROADWAY
(Street)
OAKLAND CALIFORNIA 94612-1888
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)05/08/2026A(2)V297.0104 (3) (3)Common Stock297.0104$0.000022,371.5922D
Deferred Stock Units(1)06/30/2026A(4)288.1391 (3) (3)Common Stock288.1391$0.000022,659.7313D
Explanation of Responses:
1. 1-for-1
2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
By Jinho Joo, Attorney-in-Fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Christopher J. Williams report for CLX?

Christopher J. Williams reported two awards of deferred stock units. He acquired 297.0104 units on May 8, 2026, and 288.1391 units on June 30, 2026, as part of his compensation as an independent director.

How many Clorox deferred stock units does Christopher J. Williams now hold?

After the June 30, 2026 award, Christopher J. Williams holds 22,659.7313 deferred stock units. These units reflect his accumulated director compensation, payable in Clorox stock when his board service ends through retirement or other termination.

How were the new Clorox deferred stock units granted to director Williams?

The new deferred stock units were acquired through dividend reinvestment and by taking quarterly director fees in stock units. Both mechanisms operate under Clorox’s Independent Directors' Deferred Compensation Plan for non-employee board members.

What does each Clorox deferred stock unit represent for director Williams?

Each deferred stock unit represents a 1-for-1 right to receive one share of Clorox common stock. The filing notes these units will be settled entirely in Clorox stock upon Williams’ retirement or other termination of service as a director.

Are Christopher J. Williams’ recent CLX transactions open-market buys or sells?

No, the reported transactions are not open-market buys or sells. They are classified as grant or award acquisitions of deferred stock units, reflecting director compensation and dividend reinvestment rather than discretionary trading in Clorox shares.